The association among sleep disturbance focusing on sleep related breathing disorders at home, daily activity and parameters of lifestyle disease

The association among sleep disturbance focusing on sleep related breathing disorders at home, daily activity and parameters of lifestyle disease - The association among sleep disturbance focusing on sleep related breathing disorders at home, daily activity and parameters of lifestyle disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021825

Enrollment

100

Registered

2016-05-01

Start date

2016-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep apnea (OSA)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who agree with this study

Exclusion criteria

Exclusion criteria: # Patients who are suspected to have other sleep related breathing disorders except for OSA and scheduled to undergo PSG # Patients have difficulty with wearing measuring equipment due to dementia, physically handicapped, and so on # Patients who is considered as unfit by a main researcher

Design outcomes

Primary

Measure	Time frame
The association among sleep disturbance focusing on sleep related breathing disorders at home, daily activity and parameters of lifestyle disease	—

Secondary

Measure	Time frame
To validate the measurement of sleep duration by Actiwatch 2 compared with PSG according to severity of sleep related breathing disorders. To validate that UW-301BT can measure sleep disturbance including sleep duration and daily activity, compared with Actiwatch 2 and Lifecorder. To explore the association among following items, OSA severity, sleep duration and daily activity 1) 3%ODI measured by Pulsox and Actiwatch 2 or UW-301BT 2) Sleep disturbance and activity measured by Actiwatch 2 and UW-301BT 3) Physical activity measured by Lifecorder and UW-301BT 4) Body weight and body composition 5) Sleep quality 6) Questionaires 7) Laboratory tests and urinalysis 8) Arterial blood gases 9) Visceral fat 10) Electrocardiography 11) Lung function test 12) Chest X ray 13) Vascular endothelial function measured by Endo-PAT	—

Measure

Time frame

To validate the measurement of sleep duration by Actiwatch 2 compared with PSG according to severity of sleep related breathing disorders. To validate that UW-301BT can measure sleep disturbance including sleep duration and daily activity, compared with Actiwatch 2 and Lifecorder. To explore the association among following items, OSA severity, sleep duration and daily activity 1) 3%ODI measured by Pulsox and Actiwatch 2 or UW-301BT 2) Sleep disturbance and activity measured by Actiwatch 2 and UW-301BT 3) Physical activity measured by Lifecorder and UW-301BT 4) Body weight and body composition 5) Sleep quality 6) Questionaires 7) Laboratory tests and urinalysis 8) Arterial blood gases 9) Visceral fat 10) Electrocardiography 11) Lung function test 12) Chest X ray 13) Vascular endothelial function measured by Endo-PAT

—

Countries

Japan

Contacts

Public ContactTakuma Minami

Graduate school of medicine, Kyoto University Respiratory medicine

t.373@kuhp.kyoto-u.ac.jp075-751-3830

Outcome results